Non-Interventional
OtherNon-interventional
NCT Number: NCT03432546
Approximately 20,000 patients are treated in intensive care units (ICU) in Finland annually. During ICU stay many diagnostic and other procedures as well as immobilization and underlying diseases may cause pain. Therefore the incidence of pain in ICU patients can be high. Acute pain may cause several detrimental effects including respiratory distress, tissue hypoxia, immunosuppression and anxiety. After discharge many survivors of critical care have lower health-related quality of life, symptoms of post-traumatic stress disorder or persistent pain.
Only few studies with a focus on acute or persistent pain in ICU patients have been made, hence the incidence and risk factors for ICU-related pain is not very well known. Some of the identified risk factors for persisting pain may be increased age, sepsis or inadequate pain management during ICU stay. Opioids are most often used for analgesics in intensive care. Because they may have several adverse effects the use must be based on validated pain scales. Many factors such as sedation, relaxation or delirium of the patient complicates the management of the pain.
This prospective observational study aims to determine the incidence and risk factors for acute and persistent pain in ICU patients as well as and the use of analgesics during intensive care.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Helsinki University Central Hospital, Meilahti, Helsinki, Finland
This prospective observational study aims to determine the incidence and risk factors for acute and persistent pain in ICU patients as well as and the use of analgesics during intensive care.
The recruitement process is finished, but the follow-up is on-going. Patients are followed-up by subsequent questionnaires until 5 years after admission to the ICU.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Non-interventional
Time frame: Through study completion, an average of 3 days
Moderate or severe pain (numerical rating scale (NRS) value above 3 / critical pain observatory tool (CPOT) value ≥3) during intensive care
Time frame: At intensive care follow up clinic at three months after discharge and thereafter the change in pain annually for 5 years
Moderate or severe pain.
Time frame: At intensive care follow up clinic at three months after discharge and thereafter the change in anxiety annually for 5 years
State Trait anxiety Index T (STAI-T)
Time frame: Through study completion, an average of 3 days
Analgesics administered during intensive care including indications and dosages
Time frame: Through study completion, an average of 3 days
Incidence of delirium during intensive care by using Intensive Care Delirium Screening Checklist (ICDSC, scores 0-8) scale, a sum of symptoms equal or above 4 is considered affirmative for delirium
Tampere University Hospital
Other
Acute and Persistent Pain in Intensive Care Patients
Acronym: PAIN-ICU
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04817696
Chronic Pain, Critical Care
Nantes, France
View Trial DetailsNCT03628300
Acute Kidney Injury, Beta Lactams
Amiens, France
View Trial DetailsNCT05960994
Critical Care, Intensive Care Units
São Paulo, Brazil
View Trial DetailsNCT05937646
Behavior, Communication
Chapel Hill, North Carolina, United States
View Trial Details